Table 1.
Goserelin × 24, n (%) | CMF × 6, n (%) | CMF × 6→goserelin × 18, n (%) | Total, n (%) | |
ER-positive cohort | n = 278 | n = 291 | n = 282 | n = 851 |
Age (years) | ||||
≤34 | 11 (4) | 16 (6) | 16 (6) | 43 (5) |
35–39 | 36 (13) | 36 (12) | 37 (13) | 109 (13) |
40–44 | 65 (23) | 88 (30) | 69 (24) | 222 (26) |
45–49 | 115 (41) | 105 (36) | 105 (37) | 325 (38) |
≥50 | 51 (18) | 46 (16) | 55 (20) | 152 (18) |
Primary surgical treatment | ||||
Total mastectomy | 119 (43) | 126 (43) | 121 (43) | 366 (43) |
Breast conservation | ||||
With RT planned | 148 (53) | 151 (52) | 146 (52) | 445 (52) |
With no RT planned | 11 (4) | 14 (5) | 15 (5) | 40 (5) |
Tumor size (cm) | ||||
≤1.0 | 27 (10) | 37 (13) | 44 (16) | 108 (13) |
1.1–2.0 | 149 (54) | 151 (52) | 146 (52) | 446 (52) |
>2 | 100 (36) | 98 (34) | 90 (32) | 288 (34) |
Unknown | 2 (1) | 5 (2) | 2 (1) | 9 (1) |
Tumor grade | ||||
1 | 52 (19) | 46 (16) | 77 (27) | 175 (21) |
2 | 148 (53) | 146 (50) | 129 (46) | 423 (50) |
3 | 76 (27) | 93 (32) | 74 (26) | 243 (29) |
Unknown | 2 (1) | 6 (2) | 2 (1) | 10 (1) |
ER-negative cohort | n = 65 | n = 68 | n = 72 | n = 205 |
Age (years) | ||||
≤34 | 5 (8) | 6 (9) | 4 (6) | 15 (7) |
35–39 | 15 (23) | 10 (15) | 16 (22) | 41 (20) |
40–44 | 15 (23) | 18 (26) | 22 (31) | 55 (27) |
45–49 | 24 (37) | 24 (35) | 20 (28) | 68 (33) |
≥50 | 6 (9) | 10 (15) | 10 (14) | 26 (13) |
Primary surgical treatment | ||||
Total mastectomy | 34 (52) | 31 (46) | 35 (49) | 100 (49) |
Breast conservation | ||||
With RT planned | 27 (42) | 30 (44) | 33 (46) | 90 (44) |
With no RT planned | 4 (6) | 7 (10) | 4 (6) | 15 (7) |
Tumor size (cm) | ||||
≤1.0 | 5 (8) | 5 (7) | 5 (7) | 15 (7) |
1.1–2.0 | 31 (48) | 21 (31) | 28 (39) | 80 (39) |
>2 | 29 (45) | 42 (62) | 37 (51) | 108 (53) |
Unknown | 0 (0) | 0 (0) | 2 (3) | 2 (1) |
Tumor grade | ||||
1 | 1 (2) | 2 (3) | 3 (4) | 6 (3) |
2 | 12 (18) | 16 (24) | 16 (22) | 44 (21) |
3 | 52 (80) | 49 (72) | 51 (71) | 152 (74) |
Unknown | 0 (0) | 1 (1) | 2 (3) | 3 (1) |
CMF, cyclophosphamide, methotrexate and fluorouracil; RT, radiation therapy.